Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.94 % |
3 Month Return | -4.96 % |
1 Year Return | + 64.38 % |
Market Stats | |
Previous Close | ₹1,067.30 |
Open | ₹1,082.85 |
Volume | 3,662.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹2,635.25Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹2,635.25 Cr |
P/B Ratio | 3.41 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 11.21 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,635.25 Cr | 11.8% | 0.52 | NA | NA | |
NA | ₹136.73 Cr | 9.85% | 0.59 | NA | NA | |
NA | ₹2,410.53 Cr | 173.57% | 0.62 | ₹43 Cr | ₹381 Cr | |
NA | ₹162.20 Cr | 101.48% | 0.58 | NA | NA | |
NA | ₹18,538.81 Cr | 70.96% | 0.77 | -₹472 Cr | ₹2,798 Cr |
Organisation | Novartis India Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Novartis India Ltd
Novartis India reported a 10.59% increase in net sales to Rs 87.10 crore for September 2024, but net profit fell 13.81% to Rs 20.41 crore. EBITDA also declined by 16.31%. The EPS decreased to Rs 8.27 from Rs 9.59 a year ago. Shares closed at Rs 1,055.20, with a 56.40% return over the last 12 months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.9% return, outperforming this stock by 84.4%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 28.60% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.68% of holdings in Sep 2024 quarter
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.19% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 76.6% return, outperforming this stock by 12.2%
Price Dip
In the last 3 months, NOVARTIND stock has moved down by -5.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 70.68% | 0.00 | |
Foreign Institutions | 0.19% | ||
Mutual Funds | 0% | 12.12 | |
Retail Investors | 28.6% | 0.00 | |
Others | 0.53% | 0.08 |
Novartis India Ltd’s net profit fell -13.81% since last year same period to ₹20.41Cr in the Q2 2024-2025. On a quarterly growth basis, Novartis India Ltd has generated -20.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Novartis India Ltd has declared dividend of ₹25 - translating a dividend yield of 6.70%.
Read More about DividendsBearish
Neutral
Bullish
Novartis India Ltd is currently in a Bullish trading position according to technical analysis indicators.
Novartis India Ltd (500672) share price today is ₹1082.85
Novartis India Ltd is not listed on NSE
Novartis India Ltd is listed on BSE
Today’s traded volume of Novartis India Ltd(500672) is 3,662.00.
Today’s market capitalisation of Novartis India Ltd(500672) is ₹2635.25Cr.
Novartis India Ltd(500672 | Price |
---|---|
52 Week High | ₹1248 |
52 Week Low | ₹642 |
Novartis India Ltd(500672) share price is ₹1082.85. It is down -13.23% from its 52 Week High price of ₹1248
Novartis India Ltd(500672) share price is ₹1082.85. It is up 68.67% from its 52 Week Low price of ₹642
Novartis India Ltd(500672 | Returns |
---|---|
1 Day Returns | 15.55% |
1 Month Returns | -0.94% |
3 Month Returns | -4.96% |
1 Year Returns | 64.38% |